MONOPAR THERAPEUTICS INC has a total of 30 patent applications. It increased the IP activity by 80.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL, OPTIMER PHARMACEUTICALS INC and INTERNAT MEDICAL INNOVATIONS I.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | Israel | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Mexico | 3 | |
#8 | China | 2 | |
#9 | United States | 2 | |
#10 | South Africa | 2 | |
#11 | Hong Kong | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Sugars | |
#5 | Heterocyclic compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Attali Pierre | 11 |
#2 | Walsh Gerald | 7 |
#3 | Olson Richard | 7 |
#4 | Bérangère Vasseur-Demarcy | 6 |
#5 | Pierre Attali | 6 |
#6 | Vasseur-Demarcy Bérangère | 4 |
#7 | Vasseur-Demarcy Berangere | 3 |
#8 | Vasseur Demarcy Berangere | 3 |
#9 | Richard Olson | 2 |
#10 | Gerald Walsh | 2 |
Publication | Filing date | Title |
---|---|---|
US2018230175A1 | 3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation | |
AU2016260785A1 | Clonidine and/or Clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy | |
AU2015391685A1 | Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy | |
EP2117571A2 | Urokinase-type plasminogen activator receptor epitope |